Structure Therapeutics Inc
(GPCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 73,787 | 70,451 | 56,311 | 47,061 | 45,836 |
| Operating Income | -73,787 | -70,451 | -56,311 | -47,061 | -45,836 |
| Other Income | 8,183 | 8,929 | 9,576 | 10,718 | 11,951 |
| Pre-tax Income | -65,604 | -61,522 | -46,735 | -36,343 | -33,885 |
| Income Tax | 108 | 139 | 98 | 136 | 92 |
| Net Income Continuous | -65,712 | -61,661 | -46,833 | -36,479 | -33,977 |
| Net Income | $-65,712 | $-61,661 | $-46,833 | $-36,479 | $-33,977 |
| EPS Basic Total Ops | -1.12 | -1.07 | -0.82 | -0.65 | -0.59 |
| EPS Basic Continuous Ops | -1.12 | -1.07 | -0.82 | -0.65 | -0.59 |
| EPS Diluted Total Ops | -1.12 | -1.07 | -0.82 | -0.65 | -0.59 |
| EPS Diluted Continuous Ops | -1.12 | -1.07 | -0.82 | -0.65 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.36 | -0.27 | -0.22 | -0.20 |
| EBITDA(a) | $-76,722 | $-74,500 | $-61,234 | $-52,813 | $-51,550 |